Page "Hepatitis C" Paragraph 2

The virus persists in the liver in about 85 % of those infected.

This persistent infection can be treated with medication: the standard therapy is a combination of peginterferon and ribavirin, with either boceprevir or telaprevir added in some cases.

Overall, 50 – 80 % of people treated are cured.

Those who develop cirrhosis or liver cancer may require a liver transplant.

is the leading cause of liver transplantation, though the virus usually recurs after transplantation.

No vaccine against is available.